Reports of Practical Oncology & Radiotherapy
A prospective observational study on whole brain radiotherapy with simultaneous integrated boost in one to four brain metastases
By Sattwik Basu, Shyamal Biswas, Debottam Barman and 2 others.
Abstract
Background
Patients with brain metastases, ineligible for excision or radiosurgery, usually have a poor prognosis. Even with whole brain radiotherapy (WBRT), the median survival has historically been around 4–6 months. WBRT with simultaneous integrated boost (WBRT-SIB) is one of the strategies to increase intracranial control.